论文部分内容阅读
AIM:To determine the risk of second primary malignancy(SPM)and survival of patients with essential thrombocythemia(ET).METHODS:We identified all patients with ET diagnosed during 2001 to 2011 from the Surveillance,Epidemiology and End Results(SEER)18 data